Robin Farmanfarmaian is a professional speaker, entrepreneur and angel investor actively involved in investing and advancing digital health companies poised to impact large populations. MedTech sat down with Ms. Farmanfarmaian to discuss the future of digital health.
According to the U.S. Census Bureau, the country’s senior population will nearly double by 2050: effectively becoming 20 percent of the entire population. This substantial growth, coupled with a decreasing physician population, necessitates a wide array of creative solutions to help address growing demands in senior care.
Unmanned aerial vehicles (UAVs), better knowns as drones, are being studied for various medical applications, from carrying disaster relief aid to transporting transplant organs and blood samples. When it comes to medical emergencies, each moment is critical to patient survival.
A car manufacturer has recently developed a new medical device designed to alleviate motion sickness, given that approximately 30 million people in Europe alone suffer from chronic travel sickness, and one in three people develop symptoms at least once in their lifetimes.
The Food and Drug Administration has approved the Zephyr Endobronchial Valve (Zephyr Valve), a device to treat breathing difficulty associated with severe emphysema.
Foodborne illnesses affect 48 million Americans each year, a grim statistic that leads to over 128,000 hospitalizations and 3,000 deaths, according to the U.S. Centers for Disease Control and Prevention.
Yet recent findings published June 27 in the journal Nano Letters indicate that technology can be employed to prevent consumers from buying and/or eating tainted food.
A private security firm called TrapX Labs, recently set up a sting operation to gauge the impact of hackers on hospital security systems. It documented how financially motivated computer hackers attacking a decoy hospital network can make changes in networked devices like CT scanners in ways that can compromise patient safety. The hospital network was fake, but attackers were real, TrapX said.
Now there is a device that can deliver drugs directly to a damaged area of the heart. The device, developed by MIT and Harvard researchers, delivers drugs straight to the heart through a tube. “After a heart attack we could use this device to deliver therapy to prevent a patient from getting heart failure.